Five abstracts accepted for poster presentations WARMINSTER, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma ...

The global cancer supportive care products market is set to experience steady growth, with an estimated market value of USD 20.63 billion in 2022. According to industry forecasts, this market is ...

The absence of an immune response to Serina's POZ-lipid represents a novel discovery that could enable the development of safer and more effective LNP formulations for gene therapy and RNA-based ...

The TIRG initiative continues to underscore GMU’s dedication to building international research partnerships and promoting a culture of innovation. Image Courtesy: Thumbay Group ...

The following is a summary of "Enhanced anticancer efficacy of oxaliplatin-loaded PEGylated niosomes in breast cancer ...

Both non-PEGylated and PEGylated versions of liposomal doxorubicin are in use although there are at least theoretically and, perhaps, clinically significant advantages to PEGylation. Passive Tumor ...

Palynziq substitutes the deficient phenylalanine hydroxylase (PAH) enzyme in PKU with a PEGylated version of the enzyme phenylalanine ammonia lyase to break down Phe. Palynziq is administered ...

WARMINSTER, Pa., March 27, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, ...

a plant cell-expressed recombinant PEGylated uricase for the treatment of uncontrolled gout; PRX–119, a plant cell-expressed long acting DNase I for the treatment of NETs-related diseases ...

Ruxolitinib for treating acute graft versus host disease that responds inadequately to corticosteroids in people 12 years and over TA1054 15 April 2025 15 April 2025 ...

A massive trend in the development of PEGylated drugs has been observed since the launch of ADAGEN (pegademase bovine), the first approved PEGylated protein manufactured by Enzon Pharmaceuticals in ...

However, in people with pre-existing anti-PEG antibodies, the administration of PEGylated liposomes may induce higher levels of antibodies, which may cause accelerated clearance of other PEGylated ...